Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 022253

Expand all

VIMPAT (LACOSAMIDE)
50MG
Marketing Status: Prescription

Active Ingredient: LACOSAMIDE
Proprietary Name: VIMPAT
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 50MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N022253
Product Number: 001
Approval Date: Oct 28, 2008
Applicant Holder Full Name: UCB INC
Marketing Status:  Prescription
Patent and Exclusivity Information

VIMPAT (LACOSAMIDE)
100MG
Marketing Status: Prescription

Active Ingredient: LACOSAMIDE
Proprietary Name: VIMPAT
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 100MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N022253
Product Number: 002
Approval Date: Oct 28, 2008
Applicant Holder Full Name: UCB INC
Marketing Status:  Prescription
Patent and Exclusivity Information

VIMPAT (LACOSAMIDE)
150MG
Marketing Status: Prescription

Active Ingredient: LACOSAMIDE
Proprietary Name: VIMPAT
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 150MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N022253
Product Number: 003
Approval Date: Oct 28, 2008
Applicant Holder Full Name: UCB INC
Marketing Status:  Prescription
Patent and Exclusivity Information

VIMPAT (LACOSAMIDE)
200MG
Marketing Status: Prescription

Active Ingredient: LACOSAMIDE
Proprietary Name: VIMPAT
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 200MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AB
Application Number: N022253
Product Number: 004
Approval Date: Oct 28, 2008
Applicant Holder Full Name: UCB INC
Marketing Status:  Prescription
Patent and Exclusivity Information